FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
FHIR
© HL7.org
|
Server Home |
FHIR Server FHIR Server 3.7.4-SNAPSHOT
|
FHIR Version n/a
User: [n/a]
Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Mar 2022. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4965080015 | Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4965081016 | Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4965080015 | Ruxolitinib (as ruxolitinib phosphate) 25 mg oral tablet | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4965081016 | Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Is a | Ruxolitinib only product in oral dose form | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has manufactured dose form | Conventional release oral tablet (dose form) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has unit of presentation | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Plays role | Antineoplastic therapeutic role | false | Inferred relationship | Existential restriction modifier (core metadata concept) | ||
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has precise active ingredient | Ruxolitinib phosphate (substance) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has basis of strength substance (attribute) | Ruxolitinib | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength numerator unit (attribute) | mg | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 | |
| Product containing precisely ruxolitinib (as ruxolitinib phosphate) 25 milligram/1 each conventional release oral tablet (clinical drug) | Has presentation strength denominator unit (attribute) | Tablet (unit of presentation) | true | Inferred relationship | Existential restriction modifier (core metadata concept) | 1 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets